A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 18
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : BNX
Long Form : buprenorphine-naloxone
No. Year Title Co-occurring Abbreviation
2020 How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users. ER, OUD
2020 Sexual dysfunction in men on buprenorphine - naloxone-based substitution therapy. ASEX
2019 Overdose Risk and Client Characteristics Associated With the Injection of Buprenorphine at a Medically Supervised Injecting Center in Sydney, Australia. MSIC, OR, OST
2018 Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications. BUP, MET, OMT
2017 Impact of a Mandated Change in Buprenorphine Formulation. BNX-RDT
2016 Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia. PWID
2016 Factors associated with non-adherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patients. OMT
2016 Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment. CI, NTX
2015 Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients. MET, OMT
10  2015 Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial. ---
11  2015 Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study. ---
12  2015 The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations. BPN, KEs, NSW, SA, VIC
13  2013 Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning. BPN, NOR, NX
14  2013 The effect of an electronic medicine dispenser on diversion of buprenorphine-naloxone-experience from a medium-sized Finnish city. EMDs, OST
15  2012 A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals. BPN, CI
16  2011 Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing. BPN, IDUs, MET, OST
17  2009 Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. BPN, IDUs
18  2007 Using buprenorphine short-term taper to facilitate early treatment engagement. ---